• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YKL-40——心血管疾病和糖尿病中的新兴生物标志物。

YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

机构信息

Dept of Internal Medicine, Center of Endocrinology and Metabolism, Copenhagen University Hospital Herlev, Denmark.

出版信息

Cardiovasc Diabetol. 2009 Nov 23;8:61. doi: 10.1186/1475-2840-8-61.

DOI:10.1186/1475-2840-8-61
PMID:19930630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2789050/
Abstract

Several inflammatory cytokines are involved in vascular inflammation resulting in endothelial dysfunction which is the earliest event in the atherosclerotic process leading to manifest cardiovascular disease. YKL-40 is an inflammatory glycoprotein involved in endothelial dysfunction by promoting chemotaxis, cell attachment and migration, reorganization and tissue remodelling as a response to endothelial damage. YKL-40 protein expression is seen in macrophages and smooth muscle cells in atherosclerotic plaques with the highest expression seen in macrophages in the early lesion of atherosclerosis. Several studies demonstrate, that elevated serum YKL-levels are independently associated with the presence and extent of coronary artery disease and even higher YKL-40 levels are documented in patients with myocardial infarction. Moreover, elevated serum YKL-40 levels have also been found to be associated with all-cause as well as cardiovascular mortality. Finally, YKL-40 levels are elevated both in patients with type 1 and type 2 diabetes, known to be at high risk for the development of cardiovascular diseases, when compared to non-diabetic persons. A positive association between elevated circulating YKL-40 levels and increasing levels of albuminuria have been described in patients with type 1 diabetes indicating a role of YKL-40 in the progressing vascular damage resulting in microvascular disease. This review describes the present knowledge about YKL-40 and discusses its relation to endothelial dysfunction, atherosclerosis, cardiovascular disease and diabetes and look ahead on future perspectives of YKL-40 research.

摘要

几种炎症细胞因子参与血管炎症,导致内皮功能障碍,这是动脉粥样硬化过程中导致明显心血管疾病的最早事件。YKL-40 是一种参与内皮功能障碍的炎症糖蛋白,通过促进趋化、细胞附着和迁移、重组和组织重塑来响应内皮损伤。YKL-40 蛋白表达可见于动脉粥样硬化斑块中的巨噬细胞和平滑肌细胞,在动脉粥样硬化早期病变中的巨噬细胞中表达最高。几项研究表明,血清 YKL-水平升高与冠状动脉疾病的存在和严重程度独立相关,甚至在心肌梗死患者中也记录到更高的 YKL-40 水平。此外,升高的血清 YKL-40 水平也与全因和心血管死亡率相关。最后,与非糖尿病患者相比,1 型和 2 型糖尿病患者的血清 YKL-40 水平升高,已知这些患者患心血管疾病的风险很高。在 1 型糖尿病患者中,描述了循环 YKL-40 水平升高与白蛋白尿水平升高之间的正相关,表明 YKL-40 在导致微血管疾病的血管损伤进展中发挥作用。这篇综述描述了目前关于 YKL-40 的知识,并讨论了它与内皮功能障碍、动脉粥样硬化、心血管疾病和糖尿病的关系,并展望了 YKL-40 研究的未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/2789050/e77296ca3e03/1475-2840-8-61-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/2789050/32dcc8697be3/1475-2840-8-61-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/2789050/e77296ca3e03/1475-2840-8-61-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/2789050/32dcc8697be3/1475-2840-8-61-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10c/2789050/e77296ca3e03/1475-2840-8-61-2.jpg

相似文献

1
YKL-40--an emerging biomarker in cardiovascular disease and diabetes.YKL-40——心血管疾病和糖尿病中的新兴生物标志物。
Cardiovasc Diabetol. 2009 Nov 23;8:61. doi: 10.1186/1475-2840-8-61.
2
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.YKL-40是一种炎症和内皮功能障碍的标志物,在1型糖尿病患者中升高,并随蛋白尿水平升高而增加。
Diabetes Care. 2009 Feb;32(2):323-8. doi: 10.2337/dc08-1144. Epub 2008 Oct 28.
3
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis.YKL-40,一种与胰岛素抵抗相关、在内皮功能障碍和动脉粥样硬化中起作用的新型炎症标志物。
Inflamm Res. 2006 Jun;55(6):221-7. doi: 10.1007/s00011-006-0076-y.
4
Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.来自欧洲地中海人群的1型糖尿病无症状患者中YKL-40与脂联素的关系及亚临床动脉粥样硬化
Cardiovasc Diabetol. 2015 Sep 18;14:121. doi: 10.1186/s12933-015-0287-z.
5
Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.YKL-40 水平测定的低度炎症:与老年人群总体和心血管死亡率增加的相关性。
Int J Cardiol. 2010 Aug 6;143(1):35-42. doi: 10.1016/j.ijcard.2009.01.043. Epub 2009 Feb 14.
6
YKL-40 levels are independently associated with albuminuria in type 2 diabetes.YKL-40 水平与 2 型糖尿病患者的白蛋白尿独立相关。
Cardiovasc Diabetol. 2011 Jun 22;10:54. doi: 10.1186/1475-2840-10-54.
7
YKL-40 in type 2 diabetic patients with different levels of albuminuria.YKL-40 在不同白蛋白尿水平的 2 型糖尿病患者中的表达。
Eur J Clin Invest. 2011 Jun;41(6):589-96. doi: 10.1111/j.1365-2362.2010.02446.x. Epub 2010 Dec 16.
8
YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients.YKL-40,一种心血管疾病和内皮功能障碍的标志物,在肾移植受者中的情况。
Transplant Proc. 2014 Oct;46(8):2651-3. doi: 10.1016/j.transproceed.2014.09.017.
9
Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.2 型糖尿病无症状患者中冠状动脉疾病与炎症生物标志物 YKL-40 之间的潜在关联。
Cardiovasc Diabetol. 2012 Jul 18;11:84. doi: 10.1186/1475-2840-11-84.
10
YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.YKL-40,一种新的血管内皮功能障碍生物标志物,与 2 型糖尿病患者的白蛋白尿独立相关。
Diabetes Res Clin Pract. 2011 Feb;91(2):e50-2. doi: 10.1016/j.diabres.2010.11.015. Epub 2010 Dec 15.

引用本文的文献

1
Human YKL-40 antibody alleviates atopic dermatitis-like skin inflammation by inhibiting exosome secretion via the JAK3/STAT6 pathway.人YKL-40抗体通过JAK3/STAT6途径抑制外泌体分泌,从而减轻特应性皮炎样皮肤炎症。
Arch Pharm Res. 2025 Sep 9. doi: 10.1007/s12272-025-01564-y.
2
Circulating SLC17A5 as a Diagnostic Biomarker of Early Endothelial Dysfunction in Young Dyslipidemic Individuals.循环中的溶质载体家族17成员5(SLC17A5)作为年轻血脂异常个体早期内皮功能障碍的诊断生物标志物。
J Cardiovasc Transl Res. 2025 Sep 5. doi: 10.1007/s12265-025-10689-w.
3
Maresin 1 and CHI3L1 Levels Exhibit Opposing Trends and Correlations with Renal Dysfunction in Diabetic Nephropathy.

本文引用的文献

1
YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.YKL-40,一种分泌型糖蛋白,可促进肿瘤血管生成。
Oncogene. 2009 Dec 17;28(50):4456-68. doi: 10.1038/onc.2009.292. Epub 2009 Sep 21.
2
YKL-40 is elevated in morbidly obese patients and declines after weight loss.YKL-40 在病态肥胖患者中升高,减肥后下降。
Obes Surg. 2009 Nov;19(11):1557-63. doi: 10.1007/s11695-009-9917-4. Epub 2009 Jul 25.
3
Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.
maresin 1和CHI3L1水平在糖尿病肾病中呈现相反趋势且与肾功能障碍相关。
Medicina (Kaunas). 2025 Jul 10;61(7):1247. doi: 10.3390/medicina61071247.
4
Association of serum chitinase-3-like protein 1 with sarcopenia in patients with type 2 diabetes mellitus.2型糖尿病患者血清几丁质酶-3样蛋白1与肌肉减少症的关联
J Endocrinol Invest. 2025 Jul 8. doi: 10.1007/s40618-025-02649-7.
5
Mechanistic studies on the role of CHI3L1 in eosinophilic inflammation in chronic sinusitis.几丁质酶3样蛋白1(CHI3L1)在慢性鼻窦炎嗜酸性粒细胞炎症中作用的机制研究
Front Immunol. 2025 Mar 25;16:1562546. doi: 10.3389/fimmu.2025.1562546. eCollection 2025.
6
Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis.壳三糖酶蛋白 1 是合并肌内脂肪变性的肝细胞癌患者的预后生物标志物。
BMC Cancer. 2024 Aug 23;24(1):1042. doi: 10.1186/s12885-024-12808-3.
7
Evaluation of the relationship between YKL-40 level and clinical severity in patients with Crimean-Congo hemorrhagic fever.评估克里米亚-刚果出血热患者 YKL-40 水平与临床严重程度的关系。
Pathog Glob Health. 2024 Sep;118(6):492-498. doi: 10.1080/20477724.2024.2392225. Epub 2024 Aug 14.
8
Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohort.YKL-40在肛管鳞状细胞癌中的预后和预测作用:一项多中心队列的血清学和组织学分析
Front Med (Lausanne). 2024 Jul 9;11:1372195. doi: 10.3389/fmed.2024.1372195. eCollection 2024.
9
Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study.抗瓜氨酸化蛋白抗体阳性的类风湿关节炎高危人群中,早期动脉粥样硬化标志物水平升高:一项横断面研究。
Rheumatol Int. 2024 Oct;44(10):2007-2016. doi: 10.1007/s00296-024-05659-5. Epub 2024 Jul 16.
10
Prediction of acute kidney injury incidence following acute type A aortic dissection surgery with novel biomarkers: a prospective observational study.采用新型生物标志物预测急性 A 型主动脉夹层手术后急性肾损伤的发生率:一项前瞻性观察研究。
BMC Med. 2023 Dec 18;21(1):503. doi: 10.1186/s12916-023-03215-9.
乳腺退化蛋白39(BRP-39)/几丁质酶3样蛋白1在Th2和IL-13诱导的组织反应及细胞凋亡中的作用
J Exp Med. 2009 May 11;206(5):1149-66. doi: 10.1084/jem.20081271. Epub 2009 May 4.
4
Plasma YKL-40, a new biomarker for atrial fibrillation?血浆YKL-40,一种用于心房颤动的新型生物标志物?
Europace. 2009 Aug;11(8):1032-6. doi: 10.1093/europace/eup103. Epub 2009 May 2.
5
YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.YKL-40:一种慢性炎症和致癌转化共有的新型标志物。
Methods Mol Biol. 2009;511:159-84. doi: 10.1007/978-1-59745-447-6_7.
6
High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.血清YKL-40浓度升高与稳定型冠状动脉疾病患者的心血管死亡率和全因死亡率相关。
Eur Heart J. 2009 May;30(9):1066-72. doi: 10.1093/eurheartj/ehp049. Epub 2009 Mar 6.
7
Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.YKL-40 水平测定的低度炎症:与老年人群总体和心血管死亡率增加的相关性。
Int J Cardiol. 2010 Aug 6;143(1):35-42. doi: 10.1016/j.ijcard.2009.01.043. Epub 2009 Feb 14.
8
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.YKL-40是一种炎症和内皮功能障碍的标志物,在1型糖尿病患者中升高,并随蛋白尿水平升高而增加。
Diabetes Care. 2009 Feb;32(2):323-8. doi: 10.2337/dc08-1144. Epub 2008 Oct 28.
9
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects.健康受试者血清中YKL-40浓度的昼夜、每周及长期变化。
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2603-8. doi: 10.1158/1055-9965.EPI-07-2766.
10
Plasma YKL-40: a BMI-independent marker of type 2 diabetes.血浆YKL-40:一种与体重指数无关的2型糖尿病标志物。
Diabetes. 2008 Nov;57(11):3078-82. doi: 10.2337/db08-0182. Epub 2008 Jul 23.